Cargando…

Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process

BACKGROUND: In average-risk individuals aged 50 to 75 years, there is no difference in life-years gained when comparing colonoscopy every 10 years vs. annual fecal immunochemical testing (FIT) for colorectal cancer screening. Little is known about the preferences of patients when they have experienc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yinghui, Levy, Barcey T, Daly, Jeanette M, Bergus, George R, Dunkelberg, Jeffrey C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411789/ https://www.ncbi.nlm.nih.gov/pubmed/25902770 http://dx.doi.org/10.1186/s12913-015-0841-0

Ejemplares similares

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
por: Ren, Yinan, et al.
Publicado: (2022)

Comparison of colonoscopy after colonic diverticulitis and positive fecal immunochemical tests for the detection of colorectal neoplasia
por: Nakamatsu, Dai, et al.
Publicado: (2021)

Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
por: van de Schootbrugge-Vandermeer, Hilliene J., et al.
Publicado: (2023)

Head-to-Head Diagnostic Test Accuracy Meta-analysis of Colonoscopy and Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia
por: Yaghoobi, Mohammad, et al.
Publicado: (2023)

Immunochemical Fecal Occult Blood Test for Detection of Advanced Colonic Adenomas and Colorectal Cancer: Comparison with Colonoscopy Results
por: Viana Freitas, Bianca Rosa, et al.
Publicado: (2013)

Improving Iowa Research Network Patient Recruitment for an Advance Care Planning Study
por: Schmidt, Megan E., et al.
Publicado: (2021)

Relationship between risk information on total colonoscopy and patient preferences for colorectal cancer screening options: Analysis using the Analytic Hierarchy Process
por: Katsumura, Yuichi, et al.
Publicado: (2008)

Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
por: Mikkelsen, Ellen M, et al.
Publicado: (2018)

Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System
por: Issaka, Rachel B., et al.
Publicado: (2021)

Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial
por: Strömberg, U., et al.
Publicado: (2022)

Colonoscopy Versus Fecal Immunochemical Test for Reducing Colorectal Cancer Risk: A Population-Based Case–Control Study
por: Kim, Su Young, et al.
Publicado: (2021)

Barriers and facilitators to colonoscopy following fecal immunochemical test screening for colorectal cancer: A key informant interview study
por: Kerrison, Robert S., et al.
Publicado: (2022)

Reach and effectiveness of a centralized navigation program for patients with positive fecal immunochemical tests requiring follow-up colonoscopy
por: O'Leary, Meghan C., et al.
Publicado: (2023)

Timely Colonoscopy After Positive Fecal Immunochemical Tests in the Veterans Health Administration: A Qualitative Assessment of Current Practice and Perceived Barriers
por: Mog, Ashley C., et al.
Publicado: (2022)

Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy
por: Liao, Yi, et al.
Publicado: (2018)

Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program
por: Rivero-Sánchez, Liseth, et al.
Publicado: (2018)

Risk of colorectal cancer in patients with positive results of fecal immunochemical test performed within 5 years since the last colonoscopy
por: Jung, Yoon Suk, et al.
Publicado: (2021)

Adverse events of colonoscopy in a colorectal cancer screening program with fecal immunochemical testing: a population-based observational study
por: Denis, Bernard, et al.
Publicado: (2021)

Preference and Experience of Colonic Examination for Participants Presenting to Hospitals with a Positive Fecal Immunochemical Test Result
por: Kato, Takashi, et al.
Publicado: (2020)

Profiling small RNAs in fecal immunochemical tests: is it possible?
por: Birkeland, Einar, et al.
Publicado: (2023)

Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
por: Nieuwenburg, S. A. V., et al.
Publicado: (2021)

Fecal immunochemical test (FIT) versus colonoscopy: Does knowing that a positive FIT requires a follow-up colonoscopy affect initial decision making in the US?
por: Shergill, Jaspreet, et al.
Publicado: (2022)

FIT for colonoscopy: Benefits of the faecal immunochemical test for triaging symptomatic patients
por: Symonds, Erin L., et al.
Publicado: (2022)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Public preferences for using quantitative faecal immunochemical test versus colonoscopy as diagnostic test for colorectal cancer: evidence from an online survey
por: von Wagner, Christian, et al.
Publicado: (2020)

A Global Evaluation of the Performance Indicators of Colorectal Cancer Screening with Fecal Immunochemical Tests and Colonoscopy: A Systematic Review and Meta-Analysis
por: Ding, Hanyue, et al.
Publicado: (2022)

Fuzzy analytic hierarchy process
por: Emrouznejad, Ali, et al.
Publicado: (2017)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population
por: Lee, Jeffrey K., et al.
Publicado: (2022)

Sa002 IMPACT OF THE COVID-19 PANDEMIC ON A LARGE ORGANIZED COLORECTAL CANCER SCREENING PROGRAM BASED ON FECAL IMMUNOCHEMICAL TESTING AND OPPORTUNISTIC COLONOSCOPY
por: Levin, Theodore R., et al.
Publicado: (2021)

Assessment of disease activity by fecal immunochemical test in ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2016)

Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
por: Kim, Nam Hee, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test
por: Nwankwo, Eugene C, et al.
Publicado: (2021)

Changes in Parental Perceptions of Their Care of Their Children’s Oral Health From Age 1 to 4 Years
por: Daly, Jeanette M., et al.
Publicado: (2019)

Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy
por: Cusumano, Vivy T., et al.
Publicado: (2020)

811: IMPACT OF THE COVID-19 PANDEMIC ON FECAL IMMUNOCHEMICAL TESTING, COLONOSCOPY SERVICES, AND COLORECTAL NEOPLASIA DETECTION IN A LARGE UNITED STATES COMMUNITY-BASED POPULATION
por: Lee, Jeffrey K., et al.
Publicado: (2022)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_29k1qjhpjs021da4ed3sbmc263